Procedure Explainers · Safety & Evidence

SMILE: Small Incision Lenticule Extraction—Candidacy, Recovery, and Evidence

SMILE reshapes the cornea by removing a thin disc of tissue through a small incision, without making the flap used in LASIK. The FDA cleared the procedure in 2016 for adults with myopia, with or without astigmatism; whether it suits an individual eye depends on prescription, corneal measurements, ocular health, and the exact device labeling.

Its appeal is easy to summarize: no LASIK flap, a small incision, and the possibility of useful vision soon after treatment. The decision is less simple. SMILE is not approved for every refractive error, its early vision recovery can be less crisp than LASIK’s, and “flap-free” does not mean “risk-free.” The useful question is not which procedure sounds most modern, but which trade-offs fit the patient’s eyes and priorities.

What SMILE changes—and what it does not

SMILE stands for small incision lenticule extraction. A femtosecond laser creates a lens-shaped piece of tissue, called a lenticule, within the cornea. The surgeon removes it through a short incision, changing the cornea’s shape so that light focuses more accurately on the retina. In LASIK, a flap is created, lifted, and replaced after an excimer laser reshapes the underlying tissue. PRK also uses an excimer laser to reshape the corneal surface, but the surface layer must recover rather than being replaced as a flap.

The distinction matters because the procedures alter different corneal layers and have different healing patterns. SMILE avoids a broad flap, but it still removes corneal tissue and still depends on a healthy, appropriately shaped cornea. It is not a way to bypass a thin or irregular cornea, nor does a small incision make the operation minor. The surgeon must create and extract the lenticule accurately, and the eye must heal without problematic inflammation, infection, or other complications.

SMILE is primarily used to correct myopia, with or without astigmatism, within the limits of the applicable regulatory approval and the surgeon’s assessment. It is not a general-purpose treatment for hyperopia or presbyopia. A person may still need reading glasses as age-related focusing changes develop, even if distance vision is excellent after surgery.

Who may be a candidate?

There is no single prescription number that settles candidacy. The evaluation combines the refractive prescription with corneal shape and thickness, the health of the front and back of the eye, and whether the prescription has been stable. FDA-cleared use is a starting boundary, not a personal recommendation. The surgeon should confirm that the proposed treatment falls within the current device labeling and explain any reason to choose another option.

Prescription stability and age

Adults are generally assessed for a prescription that has remained reasonably stable, commonly over at least a year. A changing prescription can continue to change after treatment; laser surgery does not stop the biological processes that cause refractive error. Age alone does not establish suitability. A younger adult may have an unstable prescription, while an older adult may have cataract or other age-related changes that make a corneal procedure the wrong first step.

Corneal shape and thickness

Corneal topography or tomography maps the cornea’s shape, while pachymetry measures its thickness. These tests help clinicians identify irregular patterns and estimate how much tissue would remain after treatment. Conditions such as keratoconus, or signs that raise concern for corneal ectasia, can make corneal laser surgery unsafe or unsuitable. There is no universal thickness cutoff that can be applied without context: the planned correction, corneal shape, and the amount and distribution of tissue removed all matter.

Eye surface and general health

Dry eye, blepharitis, allergies, active infection, and other surface problems should be assessed before surgery. Some can be treated or controlled first; others may affect the decision or expected comfort. Pregnancy and breastfeeding can affect refraction and are commonly reasons to postpone elective refractive surgery. Certain autoimmune or healing disorders, medications, prior eye surgery, and other health factors also warrant individual review. These are discussion points, not a self-diagnosis checklist.

Ask the clinician to explain any finding that makes SMILE less suitable and whether LASIK, PRK, glasses, contact lenses, or another approach changes the balance. “Not a candidate for SMILE” does not automatically mean “a candidate for another operation.”

What the evidence can—and cannot—tell you

In the United States, the FDA cleared the VisuMax SMILE procedure in 2016 for specified myopia treatment, later including myopic astigmatism. The pivotal FDA clinical study reported that, at 12 months, 99.7% of treated eyes achieved uncorrected distance vision of 20/40 or better, and 88.3% achieved 20/20 or better. Those are study outcomes, not a promise for an individual. A study population is selected according to eligibility criteria, and results depend on the measured endpoint, follow-up period, surgeon experience, and the prescription being treated.

“20/20” also does not describe every dimension of visual quality. It does not, by itself, tell a patient whether night glare, halos, dry-eye symptoms, contrast sensitivity, or fluctuating clarity occurred. When reviewing a clinic’s results, ask which patients were included, whether the figures refer to eyes or people, how many were lost to follow-up, and whether the reported result is uncorrected vision, corrected vision, or a change in prescription.

Comparative studies and systematic reviews generally find that SMILE and LASIK can produce similar distance-vision outcomes for appropriately selected people with myopia. Some studies find less early disturbance of corneal sensation or dry-eye measures after SMILE, plausibly because it does not create a wide flap. The size and duration of that difference vary across studies, and it should not be interpreted as proof that SMILE prevents dry eye. Both procedures can cause or worsen symptoms, and a person’s baseline eye-surface health remains important.

Research also compares predictability, enhancement rates, visual quality, and recovery, but study designs and follow-up periods differ. A fair comparison uses the same endpoint and similar patient groups rather than setting one clinic’s best figure beside another procedure’s average. Ask for evidence relevant to the prescription range and eye characteristics under consideration—not only an overall success percentage.

Recovery: fast enough for daily life, not always instant

Many patients notice substantially better vision soon after SMILE, but functional vision and stable, sharp vision are not the same milestone. Clarity may sharpen more gradually over the first several days than after LASIK. Temporary haze, fluctuating focus, light sensitivity, watering, or a gritty sensation can occur. Individual recovery varies, and the clinician’s instructions take precedence over a typical timeline.

Period What may be typical Practical planning
Procedure day Vision can be hazy or fluctuate; mild irritation or light sensitivity may occur. Arrange a ride home, use prescribed drops, and avoid rubbing the eyes.
First few days Many people return to routine activities relatively quickly, while sharpness may continue to improve. Follow the surgeon’s guidance on work, screens, exercise, and water exposure. Do not drive until vision meets legal requirements and the clinician says it is safe.
Following weeks Vision and comfort may continue to settle; dryness or fluctuating clarity can persist. Attend scheduled checks and use medication or lubricating drops only as directed.

LASIK often offers very rapid visual recovery, with many people seeing well enough for routine tasks the next day, although symptoms and recovery still vary. PRK usually has a slower, more uncomfortable early recovery because the surface layer must heal; functional vision may take several days and clarity can continue improving over weeks. These are broad patterns, not guarantees or a substitute for a personalized return-to-work plan.

Ask specifically when to resume driving, contact sports, swimming, eye makeup, and strenuous exercise. Advice can differ according to healing, occupation, and the surgeon’s protocol. Do not judge a procedure’s success from the first morning’s vision alone.

SMILE, LASIK, and PRK: the trade-offs in context

Factor SMILE LASIK PRK
How tissue is reshaped A femtosecond laser forms a lenticule, removed through a small incision. A flap is created; an excimer laser reshapes tissue beneath it. The corneal surface is reshaped with an excimer laser; the surface layer heals afterward.
Early recovery pattern Often quick functional recovery; clarity may sharpen over several days. Often very quick visual recovery, though dry eye and other symptoms can occur. Typically slower and more uncomfortable early healing; vision improves over days to weeks.
Flap No LASIK-style flap. Yes. No flap.
Important limitations Approval and treatment range are specific; enhancement options may be less straightforward. Flap-related considerations and dry-eye risk require assessment. Longer surface healing and discomfort; postoperative care is important.

SMILE’s flap-free design may be relevant to people with occupations or sports involving eye impact, but it does not make the cornea immune to injury. Nor does it establish that SMILE is safer for every active person. The type of activity, prescription, corneal findings, and post-operative restrictions should all be discussed. Someone with a cornea unsuitable for one procedure may also be unsuitable for another corneal laser procedure.

Enhancement planning deserves a direct conversation. Residual prescription or later regression can occur after any refractive procedure. The method for treating residual error after SMILE depends on the individual eye and local clinical practice; it may involve a surface procedure or another approach rather than simply repeating the original operation. Ask what the surgeon would consider in your case and what additional risks or costs could follow.

Risks are not erased by a smaller incision

Possible effects include dry-eye symptoms, glare, halos, starbursts, fluctuating vision, undercorrection, overcorrection, and the need for glasses or additional treatment. Less common but serious complications can include infection, inflammation, loss of best-corrected vision, or corneal weakening. The chance and significance of each outcome depend on patient factors, the procedure, and the quality of screening and follow-up.

SMILE also has technique-specific considerations. Lenticule creation and removal require careful surgical execution; difficulty separating or extracting the tissue can affect the procedure. A flap-free operation therefore has a different set of technical demands, not an absence of surgical risk. Patients should receive clear instructions about urgent symptoms and how to contact the care team after hours.

Contact the treating service promptly for severe or worsening pain, sudden loss of vision, increasing redness, discharge, or a marked change that is not part of the expected recovery described by the clinician. Do not wait for a scheduled appointment when symptoms feel urgent.

Questions that make a consultation more useful

  • Is my prescription within the current FDA-cleared range for the device you use, and has it been stable long enough?
  • What do my corneal topography or tomography and pachymetry show? Could you explain any finding that changes my options?
  • How do dry eye, pupil measurements, previous eye conditions, medications, or my work and sports affect your recommendation?
  • Why do you recommend SMILE rather than LASIK, PRK, glasses, or contact lenses for my specific measurements?
  • What are your outcomes for people with a prescription and corneal profile like mine? How are success and complications defined, and at what follow-up point?
  • What is your plan if there is residual prescription, regression, or a complication? What might an enhancement involve?
  • When may I safely return to my job, driving, exercise, swimming, and contact sports?
  • Which symptoms need an urgent call, and how can I reach the clinical team outside office hours?

A useful consultation explains uncertainty as well as expected benefits. If the recommendation depends on a measurement, ask to see or hear the result in plain language. If you feel rushed, do not understand the trade-offs, or are told that a particular procedure is risk-free, seeking another qualified opinion is reasonable.

A measured way to decide

SMILE is a well-established corneal laser option for eligible adults with myopia, with or without astigmatism, and its 2016 FDA clearance gives patients a defined regulatory reference point. Its small incision and lack of a LASIK flap are meaningful design differences. They are not guarantees of superior vision, no dry eye, or suitability for every cornea.

Compare the outcomes that matter to you: the visual result, recovery demands, eye-surface symptoms, occupational or sporting considerations, and the plan if correction is incomplete. Then compare those priorities with measured clinical findings—not a slogan or a single headline statistic. A licensed ophthalmologist or other qualified eye-care professional can interpret your examination and explain which options are medically appropriate.

This article is for education, not diagnosis or personal medical advice. Regulatory indications and clinical recommendations can change; confirm current device labeling and discuss individual risks and options with a licensed eye-care professional.

Theme